Series: Ask the IRB & IBC Experts
WCG’s IRB & IBC Review professionals get questions about clinical research all the time: from researchers, clinical team members at biopharma companies, and from members of institutional IRBs. We know that for many of the questions, the person asking is not the only one struggling with that issue. We’ve built this forum as an immediate and less formal way to share information across the clinical research community.
WCG Clinical | Insights
Should a Protocol Amendment be Submitted in Advance of Consent Form Changes?
Blog Posts
WCG Clinical | Insights
Which comes first – IRB or IBC approval?
Blog Posts
WCG Clinical | Insights
Is special safety equipment required for IBC approval?
Blog Posts
WCG Clinical | Insights
Can a protocol get IRB approval during the 30-day IND waiting period?
Blog Posts
WCG Clinical | Insights
Is informed consent needed for post-market patient registry?
Blog Posts
WCG Clinical | Insights
Ask the Experts: When Do I Report a Protocol Deviation to the IRB? Do I Need To Report a Summary of Deviations at the Time of Continuing Review?
Blog Posts
WCG Clinical | Insights
What documentation needs to be submitted to the IRB for an IND exemption request?
Blog Posts
WCG Clinical | Insights
Does research involving retrospective review of patient charts require IRB review?
Blog Posts
WCG Clinical | Insights
Is IRB review required when linking to clinicaltrials.gov postings on patient advocacy websites and newsletters?
Blog Posts
WCG Clinical | Insights